论文信息 - The effect of inhaled terbutaline on FEV1, FVC, dyspnoea and walking distance in patients with chronic obstructive lung disease. - 字舞流文

The effect of inhaled terbutaline on FEV1, FVC, dyspnoea and walking distance in patients with chronic obstructive lung disease.

T. Evald | P. Lange | J. Sindrup | S. Keittelmann

[1] H. Kreisman,et al. The relationship between pulmonary function and dyspnea in obstructive lung disease. , 1989, Chest.

[2] N. Maltbaek,et al. Effects of oral terbutaline in chronic airflow limitation. , 1989, Chest.

[3] M. Muers,et al. Reproducibility of walking test results in chronic obstructive airways disease. , 1988, Thorax.

[4] C. Wells,et al. Sustained-release theophylline reduces dyspnea in nonreversible obstructive airway disease. , 2015, The American review of respiratory disease.

[5] A. Miller,et al. Standardized lung function testing. , 1984, Bulletin europeen de physiopathologie respiratoire.

[6] R. Light,et al. Should the FVC be considered in evaluating response to bronchodilator? , 1983, Chest.

[7] M. Artvinli,et al. Dyspnoea, disability, and distance walked: comparison of estimates of exercise performance in respiratory disease. , 1978, British medical journal.

[8] G. Borg. Perceived exertion as an indicator of somatic stress. , 2019, Scandinavian journal of rehabilitation medicine.